Rash News and Research

RSS

Zika entry into India – cause for concern

The Zika virus has finally wormed its way into one of the largest and most densely populated countries in the world, India. The World Health Organization reported that surveillance efforts should be strengthened here in order to curb the menace and prevent its spread.

30 May 2017

Preventative measures can help minimize rising threat of tick-borne illnesses

Healthcare providers and researchers agree: this will be a bad year for ticks and we need use preventative measures to minimize the threat of tick-borne illnesses.

27 May 2017

Summer perils and ways to avoid, treat them

Summer can bite. It can burn or itch. It can make you extremely sick…or worse.

27 May 2017

Clinical study tests 100-year-old drug in children with autism spectrum disorder

In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.

26 May 2017

FDA grants accelerated approval to cancer treatment based on common biomarker

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker).

23 May 2017

FAU researchers use robot technology to gain insights into development of malignant melanoma

Malignant melanoma is one of the most common and dangerous types of cancer. Researchers at Friedrich-Alexander Universität Erlangen-Nürnberg investigated how and why brown pigmented moles turn into malignant melanoma using innovative robot technology.

23 May 2017

Chikungunya, dengue, and Zika viruses: three viruses in one mosquito

The study published in Nature Communications on May 19 found that Aedes aegypti, the primary mosquito that carries the Zika virus, might also transmit chikungunya and dengue viruses with one bite.

22 May 2017

Study findings shed new light on coinfection with chikungunya, dengue or Zika viruses

A new study led by Colorado State University researchers found that Aedes aegypti, the primary mosquito that carries Zika virus, might also transmit chikungunya and dengue viruses with one bite.

19 May 2017

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis.

18 May 2017

Researchers explore new treatment combination for pediatric patients with Hodgkin lymphoma

Pediatric and young adult patients whose Hodgkin lymphoma has recurred or is resistant to initial treatment can achieve remission and even cure with secondary treatments.

18 May 2017

Brisbane researchers synthetically re-create Zika virus to better understand birth defects

Brisbane researchers have synthetically re-created Zika virus in the laboratory - a breakthrough which will help to understand the virus and the fetal brain defects it causes.

17 May 2017

Infantile spasms and multiple sclerosis relapse data presented at AAN

Mallinckrodt plc, a specialty pharmaceutical company, announced new results from two company-sponsored studies: one study on use of H.P. Acthar® Gel (repository corticotropin injection) in patients with infantile spasms (IS) and a second study on the economic burden of moderate-to-severe multiple sclerosis (MS) relapse.

2 May 2017

Stereotactic radiation provides effective, noninvasive treatment option for kidney cancer patients

Kidney cancer patients may soon have an alternative to traditional treatments, new research at UT Southwestern Medical Center's Kidney Cancer Program of the Harold C. Simmons Comprehensive Cancer Center shows.

2 May 2017

Study finds shorter course of radiation therapy given after mastectomy to be safe and effective

A shorter course of radiation therapy given to breast cancer patients following mastectomy is safe and effective and cuts treatment time in half. That is according to data from a phase II clinical trial conducted by Rutgers Cancer Institute of New Jersey investigators and other colleagues who examined a hypofractionated regimen given over three weeks versus the traditional six week course of treatment.

2 May 2017

Stivarga receives expanded FDA approval for treatment of liver cancer

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.

28 Apr 2017

Study offers new hope for early attack against Alzheimer's

Catch it early. Those are watchwords in the battle against a host of illnesses, from heart disease to cancer to Type 2 diabetes.

7 Apr 2017

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine.

31 Mar 2017

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Vaccinations have begun in a multi-site Phase 2/2b clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika infection.

31 Mar 2017

FDA approves new therapy for adult patients with relapsing and primary progressive MS

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).

29 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

Rash News and Research

Zika entry into India – cause for concern

Preventative measures can help minimize rising threat of tick-borne illnesses

Summer perils and ways to avoid, treat them

Clinical study tests 100-year-old drug in children with autism spectrum disorder

FDA grants accelerated approval to cancer treatment based on common biomarker

FAU researchers use robot technology to gain insights into development of malignant melanoma

Chikungunya, dengue, and Zika viruses: three viruses in one mosquito

Study findings shed new light on coinfection with chikungunya, dengue or Zika viruses

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

Researchers explore new treatment combination for pediatric patients with Hodgkin lymphoma

Brisbane researchers synthetically re-create Zika virus to better understand birth defects

Infantile spasms and multiple sclerosis relapse data presented at AAN

Stereotactic radiation provides effective, noninvasive treatment option for kidney cancer patients

Study finds shorter course of radiation therapy given after mastectomy to be safe and effective

Stivarga receives expanded FDA approval for treatment of liver cancer

Study offers new hope for early attack against Alzheimer's

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

FDA approves new therapy for adult patients with relapsing and primary progressive MS

FDA approves new maintenance therapy for recurrent cancers

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News